stars 1 stars 2 stars 3

At ABINITIO we accelerate your path from molecule to market. Through our Science • Scale • Success (3S) framework, we bring together R&D, GMP manufacturing, and CRO clinical trial services into a single, coordinated platform—so development moves forward with clarity, efficiency, and control. We specialise in complex dosage forms, including inhaled, intranasal, oral, and advanced drug delivery systems, supporting both small and large molecules. Our capabilities span formulation development, analytical method development and validation, GMP manufacturing of clinical trial materials, and full-service clinical trial execution. By aligning R&D, manufacturing, and clinical execution from the outset, we reduce development risk, streamline timelines, and enable efficient progression into human studies.

Website https://abinitio.com.au/
Employees 20 (7 on RocketReach)
Founded 2019
Industry Pharmaceutical Manufacturing

ABINITIO Questions

Paul Young is the CEO of ABINITIO.

7 people are employed at ABINITIO.

ABINITIO is based in Camperdown, New South Wales.

Top ABINITIO Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users